Home > Resources > Company Profiles > Pfizer, Incorporated > News

Pfizer, Incorporated (PFE)

Your Name

Your Email Address *
Send a copy to me

Recipient's Email Address *

Separate multiple email addresses (max 20) with commas.

Subject *

Message

0/1500

Email Confirmation

Jeffrey B. Kindler , CEO/Chairman of the Board/Director

www.pfizer.com

Industry: Healthcare

OPEN

LAST

PREV CLOSE

CHANGE

VOLUME

Overview

News

People

Financials

Overview

A research-based, global pharmaceutical company which discovers, develops, manufactures and markets prescription medicines for humans and animals.

Portfolio Articles

Cost Cuts and Dollar Lift Pfizer
Drug maker increases its 2008 outlook.
Jan 23 2008
The Wild Blue Yonder of Markets
Two authors tout "virtuous investing," but shareholders should note the red flags.
Dec 17 2007
Pfizer Profit Plummets
Company says it has halted production of Exubera.
Oct 18 2007
The S.E.C. Inspector Calls
Securities regulator asks 300 companies to explain how they set executive pay.
Aug 31 2007
Pfizer's Big Profit Drop

A sharp decline in sales of Lipitor hurts earnings at world's biggest drug company.

Jul 18 2007

See more news on this company

News Feeds

Midday Glance: Pharmaceuticals companies AP
Oct 15 2008
Early Glance: Pharmaceuticals companies AP
Oct 15 2008
Final Glance: Pharmaceuticals companies AP
Oct 14 2008
Meltdown 101: The Dow Jones industrial average AP
Oct 13 2008
Lawsuit claims Pfizer massaged Neurontin studies Reuters
Oct 08 2008
FDA: New data show no stroke risk with inhaler AP
Oct 07 2008
Pfizer continues realigning with 3 new units AP
Oct 07 2008
Drug stocks are hammered with the broader market AP
Oct 06 2008
Drugmakers in the Dow fall with the overall market AP
Oct 06 2008
Pharmaceutical shares dip after bailout passes AP
Oct 03 2008

Portfolio Blogs

Silly Counterfeiting Statistics, Bloomberg Edition
Jun 11 2008
Lifting the Curtain on Corporate Contributions
Nov 16 2007
Pfizer Finds a New Way to Sell to Doctors
Oct 15 2007

Pfizer: Well, SEC, Do You Want Better or More?
Oct 15 2007
Comparing Members of the $170 Billion Club
Jun 25 2007

Press Releases

Zacks Analyst Blog Highlights: Pfizer, Inc., Simon Property Group, Inc., Kroger Co., Satyam Computer Services, Ltd. and Caterpillar, Inc. Oct-15-2008, 06:00AM EDT
New Data across Pfizer's Pain and Inflammation Portfolio to Be Presented at Upcoming ACR Meeting Oct-14-2008, 08:00AM EDT
Zacks Analyst Interview Highlights: CBS, France Telecom, Pfizer and BP Oct-13-2008, 06:00AM EDT
Aetna and Pfizer Present ''State of Motion'' Health Fair in Hartford to Encourage Families to Adopt Healthy Lifestyles Oct-09-2008, 11:33AM EDT
Seven Summits Research Releases Alerts on T, MA, PFE, GG, and MRO Oct-09-2008, 09:31AM EDT

News From Around the Web

News

Man's 'Viva Viagra' missile misfires in NYC court (Yahoo! News)

Oct 15 2008
Lean Times Could Strain Pfizer's Fat Dividend (Wall Street Journal Health Blog)

Oct 15 2008
Pharmaceuticals companies shares down at 10 a.m. (Canadian Business Online)

Oct 15 2008
Research and Markets: Pre-Clinical Stage Partnering Agreements in Biopharma Reveals How and Why Companies Enter Pre-Clinical Stage Licensing/Business Development (TMCnet.com)

Oct 15 2008
Pfizer Inc. v. Sachs (New York Law Journal)

Oct 14 2008
Talks may save 250 Pfizer jobs (Irish Examiner)

Oct 14 2008
Pfizer Employees Sought to Suppress Negative Neurontin Study (Wall Street Journal Health Blog)

Oct 14 2008
Bank of America, Pfizer, Safeway among big movers (The News-Times)

Oct 14 2008
Pfizer Upgraded on Value & Yield (Yahoo! Finance)

Oct 14 2008
Pfizer, Schering-Plough lead drug stocks higher (MarketWatch)

Oct 14 2008

Blogs

Fox Exec Makes Power Player List (TVNewser)

Oct 15 2008
Pfizer - attention drug reps; incoming! (PharmaGossip)

Oct 15 2008
Pfizer’s Desperate Times & Desperate Measures (Pharmalot)

Oct 13 2008
Pfizer Sues Viva Viagra Rocket Crackpot Over Trademark (Techdirt)

Oct 10 2008
Earnings preview: Will Johnson & Johnson deliver healthy results? (Blogging Stocks)

Oct 10 2008

Employees

Number of Employees: 86,600

Revenue per Employee: $496,051

Top Executives

Margaret M. Foran, Divisional Senior VP/Secretary/Other Corporate Officer

Martin Mackay, President, Divisional/Senior VP

Natale S. Ricciardi, Divisional President/Senior VP

William C. Steere, Jr., Director/Other Corporate Officer

Allen P. Waxman, General Counsel/Senior VP

Loretta V. Cangialosi, Vice President/Controller

Frank A. D'Amelio, CFO

Dr.Corey S. Goodman, Ph.D., President, Divisional/Senior VP

M. Anthony Burns, Director/Other Corporate Officer

Ian C. Read, President, Divisional/Senior VP

Dr. Joseph M. Feczko, Chief Medical Officer/Senior VP

Sally Susman, Senior VP/Other Executive Officer

Mary S. McLeod, Senior VP, Divisional

Richard H. Bagger, Senior VP, Divisional

Board of Directors

Constance J. Horner, Director

Margaret M. Foran, Divisional Senior VP/Secretary/Other Corporate Officer

William H. Gray, III, Director

Dr. Dennis A. Ausiello, M.D., Director

William C. Steere, Jr., Director/Other Corporate Officer

Suzanne Nora Johnson, Director

Dr. Dana G. Mead, Director

M. Anthony Burns, Director/Other Corporate Officer

Robert N. Burt, Director

Dr.Michael S. Brown, M.D., Director

W. Don Cornwell, Director

George A. Lorch, Director

William R. Howell, Director

James M. Kilts, Director

Financials

Quarterly

Annual

Income Statement	07/2008	04/2008	01/2008	10/2007
Sales	2.95 Bil.	2.76 Bil.	3.38 Bil.	4.02 Bil.
Gross Operating Profit	9.18 Bil.	9.08 Bil.	9.68 Bil.	7.97 Bil.
Operating Income before D & A (EBITDA)	3.35 Bil.	3.8 Bil.	2.77 Bil.	2.2 Bil.
Total Income Before Interest Expenses (EBIT)	2.79 Bil.	3.56 Bil.	3.16 Bil.	636 Mil.
Total Net Income	2.78 Bil.	2.78 Bil.	2.88 Bil.	761 Mil.
Basic EPS, Total	0.41	0.41	0.42	0.11
Diluted EPS, Total	0.41	0.41	0.42	0.11

BALANCE STATEMENT	07/2008	04/2008	01/2008	10/2007
Cash and Equivalents	NA	NA	NA	2.61 Bil.
Total Assets	NA	NA	NA	41.84 Bil.
Total Liabilities	NA	NA	NA	14.33 Bil.
Total Capitalization	NA	NA	NA	72.65 Bil.

Cash Flow	07/2008	04/2008	01/2008	10/2007
Net Cash From Continuing Operations	NA	NA	NA	9.45 Bil.
Net Cash From Investing Activities	NA	NA	NA	3.59 Bil.
Net Cash From Financing Activities	NA	NA	NA	-12.41 Bil.
Net Change in Cash & Cash Equivalents	NA	NA	NA	784 Mil.

Income Statement	2008	2007	2006	2005
Sales	14.37 Bil.	5.61 Bil.	6.36 Bil.	5.81 Bil.
Gross Operating Profit	34.25 Bil.	42.76 Bil.	44.94 Bil.	46.7 Bil.
Operating Income before D & A (EBITDA)	10.53 Bil.	19.58 Bil.	20.5 Bil.	22.12 Bil.
Total Income Before Interest Expenses (EBIT)	9.47 Bil.	13.52 Bil.	12 Bil.	14.35 Bil.
Total Net Income	7.68 Bil.	19.34 Bil.	8.08 Bil.	11.36 Bil.
Basic EPS, Total	1.2	2.67	1.1	1.51
Diluted EPS, Total	1.2	2.66	1.09	1.49

BALANCE STATEMENT	2008	2007	2006	2005
Cash and Equivalents	NA	1.83 Bil.	2.25 Bil.	1.81 Bil.
Total Assets	NA	46.95 Bil.	41.9 Bil.	39.69 Bil.
Total Liabilities	NA	21.39 Bil.	28.45 Bil.	26.46 Bil.
Total Capitalization	NA	76.9 Bil.	71.97 Bil.	75.56 Bil.

Cash Flow	2008	2007	2006	2005
Net Cash From Continuing Operations	NA	27.84 Bil.	14.73 Bil.	16.34 Bil.
Net Cash From Investing Activities	NA	5.1 Bil.	-5.07 Bil.	-9.42 Bil.
Net Cash From Financing Activities	NA	-23.1 Bil.	-9.22 Bil.	-6.63 Bil.
Net Change in Cash & Cash Equivalents	NA	-420 Mil.	439 Mil.	288 Mil.

Pfizer, Incorporated (PFE)

Company Information

Overview

Employees

Top Executives

Board of Directors

Financials

Company Profile Change Request